000 01360 a2200409 4500
005 20250515113355.0
264 0 _c20080422
008 200804s 0 0 fre d
022 _a0013-7006
024 7 _a10.1016/j.encep.2007.01.005
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPapetti, F
245 0 0 _a[Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
_h[electronic resource]
260 _bL'Encephale
_cOct 2007
300 _a811-8 p.
_bdigital
500 _aPublication Type: Case Reports; English Abstract; Journal Article
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xpharmacokinetics
650 0 4 _aBrain
_xmetabolism
650 0 4 _aClozapine
_xpharmacokinetics
650 0 4 _aCytochrome P-450 Enzyme System
_xmetabolism
650 0 4 _aFluvoxamine
_xpharmacokinetics
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aSchizophrenia
_xdrug therapy
700 1 _aMorel-Pingault, V
700 1 _aBuisse, V
700 1 _aMaziere, L
700 1 _aBanayan, M
700 1 _aThauby, S
700 1 _aBesnard, T
700 1 _aDarcourt, G
700 1 _aPringuey, D
773 0 _tL'Encephale
_gvol. 33
_gno. 5
_gp. 811-8
856 4 0 _uhttps://doi.org/10.1016/j.encep.2007.01.005
_zAvailable from publisher's website
999 _c17858654
_d17858654